MyState Limited maintains its juicy 5.7% dividend yield

MyState reports slightly lower results but maintains its dividend

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

MyState Limited (ASX: MYS) today announced its financial results for the 2016-17 financial year.

The highlights of the result include a statutory net profit of $30.1 million, up 6% on the prior corresponding period's (pcp's) statutory profit, but down 3% on an underlying basis (if adjustments for one-off costs related to M&A and its accelerated write down of intangible software assets are excluded).

Total revenue for the company came in at $124.6m which is 1% higher than the pcp and its net interest margin fell almost 10% to from 2.13 to 1.93 basis points.

Its final dividend is flat and remains at 14.5 cents fully franked which is expected to be paid on 13 September 2017 for those shareholders holding the shares prior to the ex-dividend date of 23 August 2017.

At first glance, it looked to be a fairly unexciting result for a company that has experienced declines in its net interest margin whilst attempting to grow its customer base away from its Tasmanian roots.

But growing nationally is exactly what it's doing with loans outside of Tasmania now making up more than 50% of the total. Its total loan book is up almost 11% to $4.3 billion, and its deposits are also growing strongly totalling almost $3b.

For shareholders who can take a longer-term view, there's a lot to like despite the competitive environment it operates in.

With one-off expenses related to a number of technology projects out of the way, management are expecting to see further cost reductions and revenue gains as they grow their market share which will help to offset any further margin decline.

Its lending criteria appears to remain very robust despite the growth its achieving outside of Tasmania. Loans 30 days in arrears fell 27% to 0.51% and its loans 90 days in arrears have been kept at 0.28%, well below that of National Australia Bank Ltd. (ASX:NAB) which reports the same metric at 0.80%.

Capital adequacy remains outstanding at 13.3% and well above the Australian Prudential Regulatory Authority's 2020 CET1 ratio target of at least 10.5%.

Its wealth management arm has exhibited good progress too with funds under management growing 8% to $1,089m despite a fall in revenue from its Trustee Services division.

Its outlook is positive given it's been able to combine its core banking platforms into one and offer its customers a contemporary digital offering. This should include its New Payments Platform by the end of the year which is intended to allow customers the ability to transfer money in real time. Customer service, therefore, will be a key competitive advantage in the future and MyState looks well placed as long as it can stabilise its net interest margins.

MyState is currently yielding a fully-franked dividend of 5.7% and will serve yield-seeking investors well. But one stock doesn't make a portfolio. To help you build a collection of quality high income-paying stocks, look no further than the report below which highlights which 3 dividend-paying stocks you can pay right now.

Motley Fool contributor Edward Vesely has no position in any stocks mentioned. The Motley Fool Australia owns shares of MyState Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »